Medtronic’s Concerto Versa Detachable Coil Used in First Commercial Procedures

May 14, 2026—Medtronic announced the first procedures were performed using the Concerto Versa coil, indicated for arterial and venous embolization in the peripheral vasculature to help control bleeding or treat vascular disease. The Concerto Versa coil has FDA clearance and is currently available in the United States, advised the company.

The procedures were conducted by interventional radiologists Rahul Patel, MD, and Gloria Salazar, MD. Dr. Patel is with The Mount Sinai Hospital in New York, New York, and Dr. Salazar is with UNC Hospitals in Chapel Hill, North Carolina.

“The ability to reposition the coil easily adds a level of control that’s very helpful,” commented Dr. Patel in Medtronic’s press release.

Dr. Salazar added, “Whenever you’re dealing with tortuous anatomy, dual catheter compatibility becomes critical. If you can’t reach the target, you can’t treat it. Once you are in position, you need stability—that’s where smooth and controlled deployment really matters.”

According to Medtronic, the Concerto Versa coil is specifically designed for large vessels. The large-volume coil is compatible with many catheters while still maintaining optimal control. The Concerto Versa delivers more compatibility, volume, and control for peripheral embolization while maintaining the small-coil capabilities of the Medtronic Concerto helix and three-dimensional coils, noted the company.

Additionally, Medtronic stated that the Concerto Versa coil has the flexibility to be used with both a diagnostic catheter or microcatheter, provides more efficient procedure time with shorter catheterization time and less radiation exposure during catheterization, and has thick diameters and longer lengths to reduce the number of coils needed per procedure.